Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |